US · Healthcare

HUTCHMED (China) Limited (HMDCF)

Drug Manufacturers - Specialty & Generic

HUTCHMED (China) Limited (HMDCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HMDCF

P/E ratio

18.00

HUTCHMED (China) Limited (HMDCF) — FAQ

What is HMDCF's P/E ratio?

The price-to-earnings (P/E) ratio for HUTCHMED (China) Limited (HMDCF) is 18.00 (data as of 2026-03-24).

Does HUTCHMED (China) Limited pay a dividend?

Dividend yield is not available in the current snapshot for HUTCHMED (China) Limited (HMDCF). Check the MyAverix Finance app for the latest dividend data.

What sector is HUTCHMED (China) Limited in?

HUTCHMED (China) Limited (HMDCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is HMDCF listed on?

HMDCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)